Showing results (111-120 of 239) with videos related to
Sort By:
Pageof 24
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|September 10, 1999
[Prenatal and neonatal management of digestive tract duplications. Diagnostic difficulties and therapeutic implications]F Becmeur, B Viville, B Langer, et al.Cancer Drug Delivery|January 1, 1985
Dosage predictions in high-dose methotrexate infusions. Part 2: Bayesian estimation of methotrexate clearanceR Bruno, A Iliadis, R Favre, et al.Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 1, 1993
Predictive value of transvaginal uterine Doppler assessment in an in vitro fertilization programR Favre, K Bettahar, G Grange, et al.Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|July 1, 1995
Spontaneous regression of fetal pulmonary sequestrationB Langer, L Donato, C Riethmuller, et al.La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|March 8, 1980
[The association of lupus and Hodgkin's disease. A case history (author's transl)]A P Blanc, J A Gastaut, P Lefevre, et al.Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|December 23, 2014
[A rare case of caudal appendage]S Andres, T Boisramé, G Fritz, et al.Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 28, 2014
[Klippel-Trenaunay syndrome and pregnancy: difficult choice of delivery from a case and a review of the literature]A Koch, G Aïssi, A Gaudineau, et al.Cancer Drug Delivery|January 1, 1985
Dosage predictions in high-dose methotrexate infusions. Part 1: Evaluation of the classic test-dose protocolJ P Cano, R Bruno, N Lena, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 27, 2014
Placental abruption: risk factors, management and maternal-fetal prognosis. Cohort study over 10 yearsT Boisramé, N Sananès, G Fritz, et al.European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancerF Caponigro, C Dittrich, J B Sorensen, et al.Pageof 24